Table 1.
Baseline clinical characteristics among the groups.
| Standard care group (n = 91) | Telemonitoring group | p | |||
|---|---|---|---|---|---|
| Infrequent users (n = 54) | Frequent users (n = 53) | p* | |||
| Age, yr | 56.4 ± 8.7 | 53.5 ± 9.6 | 55.8 ± 9.9 | 0.225 | 0.209 |
| Sex, male, % (n) | 60.4 (55) | 58.2 (32) | 67.3 (35) | 0.550 | 0.594 |
| Weight, kg | 104.4 ± 20.0 | 104.2 ± 20.8 | 104.4 ± 15.9 | 0.949 | 0.996 |
| BMI, kg/m² | 35.5 ± 6 | 35.5 ± 6.5 | 34.1 ± 6.4 | 0.264 | 0.408 |
| SBP, mmHg | 127.3 ± 17.1 | 126.8 ± 15.4 | 129.0 ± 16.1 | 0.343 | 0.776 |
| LDL-C, mg/dL | 88.4 ± 31.6 | 91.7 ± 35.4 | 90.6 ± 37.5 | 0.876 | 0.840 |
| Fructosamine, µmol/L | 324 ± 73.2 | 306.5 ± 57.8 | 324.8 ± 76.8 | 0.166 | 0.283 |
| HbA1c, % | 9.2 ± 1.5 | 9.4 ± 1.4 | 9.2 ± 1.4 | 0.461 | 0.602 |
| Self-efficacy scale | 144.8 ± 34.3† | 142.0 ± 30.0† | 161.6 ± 27.6 | <0.001‡ | 0.002‡ |
Data are expressed as the mean ± SD. *p value between telemonitoring groups. †No differences between the groups with the same superscript symbol in post-hoc analyses. ‡p < 0.05.